Cutaneous and Ocular Toxicology
ISSN 1556-9527 · Taylor & Francis · United Kingdom · active 1979–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Cutaneous and Ocular Toxicology a predatory journal?
Our screening does not flag Cutaneous and Ocular Toxicology. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Cutaneous and Ocular Toxicology indexed in Scopus or Web of Science?
Per our venue index, Cutaneous and Ocular Toxicology appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Cutaneous and Ocular Toxicology's impact?
Papers in Cutaneous and Ocular Toxicology are cited about 1.3 times each within two years of publication, and Scimago places it in Q2, with an h-index of 46. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Cutaneous and Ocular Toxicology open access?
We hold no reliable open-access classification for Cutaneous and Ocular Toxicology. Check the journal's own site for its access model and any article processing charge.
Similar venues
- Progress in Retinal and Eye ResearchQ1 · Elsevier BV
- Asia-Pacific Journal of OphthalmologyQ1 · Lippincott Williams & Wilkins
- Seminars in OphthalmologyQ1 · Taylor & Francis
- Survey of OphthalmologyQ1 · Elsevier BV
- Expert Opinion on Emerging DrugsQ2 · Taylor & Francis
- JAMA OphthalmologyQ1 · American Medical Association